Soleus Capital Management, L.P. 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Soleus Capital Management, L.P. disclosed 86 US equity positions worth $1.2bn in its Q3 2024 13F filing. The largest position was IOVA at 6.7% of the reported book, followed by TGTX and 430.
What did Soleus Capital Management, L.P. own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 6.7% | $80.1m | 8,528,500 | – | |
| 2 | TGTX TG THERAPEUTICS INC | Healthcare | 4.9% | $59.3m | 2,534,540 | – | |
| 3 | 430 TERNS PHARMACEUTICALS INC | 4.3% | $51.9m | 6,223,544 | – | ||
| 4 | AXGN AXOGEN INC | Healthcare | 3.5% | $42.1m | 3,005,943 | – | |
| 5 | GRFS GRIFOLS S A | Healthcare | 3.3% | $40.2m | 4,521,703 | – | |
| 6 | KRYS KRYSTAL BIOTECH INC | Healthcare | 3.3% | $39.5m | 216,979 | – | |
| 7 | CCCC C4 THERAPEUTICS INC | Healthcare | 3.1% | $37.6m | 6,603,996 | – | |
| 8 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.0% | $36.5m | 101,894 | – | |
| 9 | SNY SANOFI | 2.9% | $35.3m | 612,000 | – | ||
| 10 | ORGO ORGANOGENESIS HLDGS INC | Healthcare | 2.8% | $33.9m | 11,839,876 | – | |
| 11 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 2.8% | $33.2m | 1,049,314 | – | |
| 12 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.7% | $32.0m | 704,584 | – | |
| 13 | QDEL QUIDELORTHO CORP | Healthcare | 2.6% | $31.3m | 686,000 | – | |
| 14 | EPIEUR ESSA PHARMA INC | 2.2% | $26.0m | 4,288,167 | – | ||
| 15 | JSPR JASPER THERAPEUTICS INC | 2.1% | $25.3m | 1,343,665 | – | ||
| 16 | SU6 SURMODICS INC | 2.1% | $24.7m | 637,698 | – | ||
| 17 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.0% | $23.9m | 1,065,834 | – | |
| 18 | TXG 10X GENOMICS INC | Healthcare | 1.8% | $21.5m | 951,000 | – | |
| 19 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.7% | $21.0m | 1,090,984 | – | |
| 20 | MERUS N V | 1.7% | $19.9m | 398,321 | – | ||
| 21 | CSTL CASTLE BIOSCIENCES INC | Healthcare | 1.6% | $18.9m | 662,332 | – | |
| 22 | EDAP TMS S A | 1.5% | $18.6m | 7,309,254 | – | ||
| 23 | ONC BEIGENE LTD | Healthcare | 1.5% | $18.6m | 82,750 | – | |
| 24 | CELC CELCUITY INC | Healthcare | 1.5% | $18.6m | 1,245,387 | – | |
| 25 | LLY ELI LILLY & CO | Healthcare | 1.4% | $17.1m | 19,300 | – | |
| 26 | NPCE NEUROPACE INC | 1.4% | $17.0m | 2,433,168 | – | ||
| 27 | EOLS EVOLUS INC | Healthcare | 1.4% | $16.8m | 1,037,680 | – | |
| 28 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.4% | $16.3m | 59,400 | – | |
| 29 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.3% | $16.0m | 269,000 | – | |
| 30 | ELV ELEVANCE HEALTH INC | Healthcare | 1.3% | $15.4m | 29,650 | – | |
| 31 | RIGL RIGEL PHARMACEUTICALS INC | 1.3% | $15.1m | 934,788 | – | ||
| 32 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.2% | $14.9m | 259,398 | – | |
| 33 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.1% | $13.0m | 224,600 | – | |
| 34 | CGON CG ONCOLOGY INC | Healthcare | 1.1% | $12.9m | 340,585 | – | |
| 35 | IMUX IMMUNIC INC | Healthcare | 1.0% | $12.0m | 7,293,007 | – | |
| 36 | BHC BAUSCH HEALTH COS INC | Healthcare | 1.0% | $11.6m | 1,424,000 | – | |
| 37 | PHVS PHARVARIS N V | 0.9% | $11.1m | 598,169 | – | ||
| 38 | LONGBOARD PHARMACEUTICALS IN | 0.9% | $10.6m | 318,269 | – | ||
| 39 | OFIX ORTHOFIX MED INC | Healthcare | 0.8% | $9.5m | 606,933 | – | |
| 40 | VSTM VERASTEM INC | Healthcare | 0.7% | $8.5m | 2,827,963 | – | |
| 41 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.7% | $8.1m | 785,546 | – | |
| 42 | KIDS ORTHOPEDIATRICS CORP | Healthcare | 0.7% | $7.8m | 288,945 | – | |
| 43 | ACLXGBX ARCELLX INC | 0.6% | $7.8m | 93,031 | – | ||
| 44 | NUVALENT INC | 0.6% | $7.6m | 74,357 | – | ||
| 45 | KINIKSA PHARMACEUTICALS INTL | 0.6% | $7.6m | 302,500 | – | ||
| 46 | BDSX BIODESIX INC | 0.6% | $7.2m | 4,038,065 | – | ||
| 47 | TAK TAKEDA PHARMACEUTICAL CO LTD | Healthcare | 0.6% | $7.1m | 500,000 | – | |
| 48 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.5% | $6.4m | 910,000 | – | |
| 49 | SMMT SUMMIT THERAPEUTICS INC | Healthcare | 0.5% | $6.2m | 285,000 | – | |
| 50 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.5% | $6.1m | 239,705 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.